ER

Eragam Reddy Vijaya

Active Director Director DIN 09056235
DIN 09056235 First appointment Mar 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Eragam Reddy Vijaya

Data last updated:

Eragam Reddy Vijaya is a Director at Preside Pharmaceutical Private Limited (since 2021). The company operates in Pharma. Preside Pharmaceutical Private Limited reported revenue of ₹32.5 Lakh (FY 2020).

DIN 09056235
Primary Designation Director
Industry Pharma
First Appointment 10 Mar 2021
Oldest Company Age 8 yrs
Largest company Preside Pharmaceutical Private Limited · ₹32.5 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Mar 20212017₹32.5 Lakh (FY 2020)Active

Board colleagues of Eragam Reddy Vijaya

Directorship timeline

Open interactive timeline →
Preside Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Eragam Reddy Vijaya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Eragam Reddy Vijaya

Eragam Reddy Vijaya currently holds 1 directorship: Preside Pharmaceutical Private Limited (Director, since 10 Mar 2021, revenue ₹32.5 Lakh (FY 2020)).

Eragam Reddy Vijaya was first appointed on 10 Mar 2021 as Director at Preside Pharmaceutical Private Limited.

The current boards of Eragam Reddy Vijaya's companies include Eragam Reddy Naga Praveen Kumar Reddy (Preside Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available